[Pubmed] COVID-19-associated damage of the peripheral nervous system
Posté : 28 sept. 2022 12:00
Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(9):15-21. doi: 10.17116/jnevro202212209115.
ABSTRACT
Based on the available literature data, the article discusses the prevalence of various forms of damage of the peripheral nervous system in COVID-19 and in the post-COVID period. Information about the clinical features and the course of individual cranial neuropathies, chronic dysimmune neuropathies, Guillain-Barré syndrome, drug-induced neuropathies, fine fiber neuropathy, myasthenia gravis and polyneuropathy of critical conditions was systemized in the context of coronavirus infection. SARS-CoV-2 can trigger various stages of pathogenesis, including neuroimmune ones, which cause long-term consequences of COVID-19, including those associated with the damage of the peripheral nervous system. Awareness of COVID-19-associated pathological conditions will allow assessment of the possible risks of damage of the peripheral nervous system, recognize them at early stages and develop more effective approaches for treatment.
PMID:36168683 | DOI:10.17116/jnevro202212209115
Source: https://pubmed.ncbi.nlm.nih.gov/3616868 ... 5&v=2.17.8